The Vice President, Clinical Development, I&I provides medical and strategic leadership for Equillium’s clinical portfolio. The role has primary responsibility for clinical development of EQ504 in ulcerative colitis and pulmonary indications, and secondary support for EQ302 in celiac disease. The position leads the integrated clinical development strategy and plan for EQ504 in ulcerative colitis, including indication strategy, target product profile, evidence-generation plan, decision criteria, timelines, and budgets. It also provides medical leadership for the ongoing EQ504 Phase 1 proof-of-mechanism study and leads planning and design of a subsequent Phase 2 ulcerative colitis study, subject to supportive Phase 1 results. The VP develops clinical and regulatory documents, provides medical oversight of trials, guides clinical pharmacology, biomarker, and translational strategies, and contributes to portfolio, business development, financing, and investor activities. Success includes timely clinical and regulatory milestones, disciplined risk management, strong investigator and advisor engagement, and effective cross-functional leadership.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Executive
Education Level
Ph.D. or professional degree